Related Experiment Video
Updated: Jul 19, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Paediatric oncology.
1University of Mainz, Department of Pediatrics, Division of Hematology/Oncology, Mainz, Germany.
Current Opinion in Urology
|October 14, 2006
Summary
Paediatric urologic oncology research now allows tailored treatments for neuroblastoma and Wilms' tumour subgroups, considering side effects and costs. Individualized surgery, radiotherapy, and chemotherapy are crucial, though bladder and prostate rhabdomyosarcoma management remains debated.
Area of Science:
- Paediatric Urologic Oncology
- Cancer Subgroup Identification
- Personalized Cancer Treatment
Background:
- Advances in paediatric urologic oncology have identified distinct subgroups within neuroblastoma and Wilms' tumour.
- This allows for more individualized treatment strategies, addressing both clinical outcomes and financial considerations.
Purpose of the Study:
- To highlight the importance of tailored treatment approaches in paediatric urologic oncology.
- To discuss the individualized roles of surgery, radiotherapy, and cytostatic treatment.
- To acknowledge unresolved controversies in managing specific paediatric urologic cancers.
Main Methods:
- Review of recent research in paediatric urologic oncology.
- Analysis of treatment modalities including surgery, radiotherapy, and chemotherapy.
- Identification of specific tumour subgroups and their management implications.
Main Results:
- Identification of specific subgroups in neuroblastoma and Wilms' tumour.
- Emphasis on the need for individualized treatment plans based on tumour characteristics.
- Recognition of ongoing debates in the management of rhabdomyosarcoma of the bladder and prostate.
Conclusions:
- Subgroup identification in paediatric neuroblastoma and Wilms' tumour enables personalized treatment.
- Individualized application of surgery, radiotherapy, and chemotherapy is essential.
- Management strategies for paediatric rhabdomyosarcoma of the bladder and prostate require further research and consensus.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...